Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Januar 2021 09:27 ET | Quelle: Biomerica, Inc.

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021 FDA actively reviewing Company’s EUA submission for its...
12. Januar 2021 08:19 ET | Quelle: Biomerica, Inc.

Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

Biomerica receives first orders and plans to ship tests in coming weeks Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement...
09. Dezember 2020 08:19 ET | Quelle: Biomerica, Inc.

Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment

Patient enrollment completion anticipated by the end of April 2021InFoods® Diagnostic-Guided Therapy is designed to address the $30 billion market for IBS treatmentTherapy seeks to identify...
16. Oktober 2020 09:27 ET | Quelle: Biomerica, Inc.

Biomerica Reports Fiscal 2021 1st Quarter Financial Results

IRVINE, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August...
01. September 2020 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Reports Fiscal Year End May 31, 2020 Financial Results

Fiscal fourth quarter revenues increase 133.7% over the prior yearFiscal 2020 revenues increase 28.7% over fiscal 2019 New InFoods® patent granted for Singapore IRVINE, Calif., Sept. 01, 2020 ...
31. August 2020 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors

IRVINE, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced today the retirement of Janet Moore, the Company’s Chief Financial Officer. After many years of...
12. August 2020 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests

IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for Biomerica’s...
22. Juli 2020 06:39 ET | Quelle: Biomerica, Inc.

Biomerica Announces Filing of New Three Year Shelf Registration Statement

IRVINE, Calif., July 22, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has filed a new three year shelf registration statement on Form S-3 with the United States...
29. Juni 2020 21:39 ET | Quelle: Biomerica, Inc.

The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial

InFoods® Diagnostic-Guided Therapy is designed to identify patient-specific foods that, when removed from the diet, may alleviate an individual's IBS symptoms Approximately 45 million Americans...
16. Juni 2020 08:19 ET | Quelle: Biomerica, Inc.

Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

This high-volume laboratory test will allow for collection of blood samples using a simplified proprietary blood collection device once cleared by the FDA. This test adds to the previously announced...

Vorherige Seite

Nächste Seite